AU2704092A - Salts of hydrazones - Google Patents

Salts of hydrazones

Info

Publication number
AU2704092A
AU2704092A AU27040/92A AU2704092A AU2704092A AU 2704092 A AU2704092 A AU 2704092A AU 27040/92 A AU27040/92 A AU 27040/92A AU 2704092 A AU2704092 A AU 2704092A AU 2704092 A AU2704092 A AU 2704092A
Authority
AU
Australia
Prior art keywords
acids
acid
unsubstituted
substituted
apart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU27040/92A
Other versions
AU658931B2 (en
Inventor
Giorgio Dr. Caravatti
Jorg Dr. Frei
Jaroslav Dr. Stanek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2704092A publication Critical patent/AU2704092A/en
Application granted granted Critical
Publication of AU658931B2 publication Critical patent/AU658931B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: CIBA-GEIGY AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Detergent Compositions (AREA)
  • Cereal-Derived Products (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention relates to acid addition salts of bases of the formula I <IMAGE> in which A, R1, R2, R3, R4, R5, X and Z have the meanings given in the description, with an acid [PA], which denotes a mono- or polybasic acid selected from carbonic acid, alkanoic acids which are unsubstituted or monosubstituted to polysubstituted, apart from formic acid, unsubstituted acetic acid, lysine and arginine; alkenoic acids which are unsubstituted or substituted, apart from unsubstituted fumaric acid, cycloalkylcarboxylic acids, arylcarboxylic acids, aryl-lower alkylcarboxylic acids in which lower alkyl is unsubstituted or substituted, aryl-lower alkenylcarboxylic acids, heterocyclylcarboxylic acids, alkanesulphonic acids which are unsubstituted or substituted, apart from unsubstituted methanesulphonic acid, aromatic sulphonic acids, alkylsulphuric acids, N-substituted sulphamic acids, organic acids without carboxyl, sulpho, sulphate or phospho groups, and further from pyrophosphoric acid and hydrogen iodide; and tautomers thereof. The acid addition salts are employed for the treatment of disorders which respond to inhibition of S-adenosylmethionine decarboxylase.
AU27040/92A 1991-10-16 1992-10-14 Salts of hydrazones Ceased AU658931B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3041/91 1991-10-16
CH304191 1991-10-16

Publications (2)

Publication Number Publication Date
AU2704092A true AU2704092A (en) 1993-04-22
AU658931B2 AU658931B2 (en) 1995-05-04

Family

ID=4247296

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27040/92A Ceased AU658931B2 (en) 1991-10-16 1992-10-14 Salts of hydrazones

Country Status (24)

Country Link
EP (1) EP0538193B1 (en)
JP (1) JP2788579B2 (en)
KR (1) KR100265307B1 (en)
AT (1) ATE145896T1 (en)
AU (1) AU658931B2 (en)
CA (1) CA2080545C (en)
CY (1) CY2127B1 (en)
CZ (1) CZ279601B6 (en)
DE (1) DE59207617D1 (en)
DK (1) DK0538193T3 (en)
ES (1) ES2095444T3 (en)
FI (1) FI112212B (en)
GR (1) GR3021903T3 (en)
HK (1) HK1005023A1 (en)
HU (1) HU226954B1 (en)
IL (1) IL103448A (en)
MX (1) MX9205934A (en)
NO (1) NO178108C (en)
NZ (1) NZ244725A (en)
RU (1) RU2081108C1 (en)
SA (1) SA93130417B1 (en)
SG (1) SG43185A1 (en)
SK (1) SK279938B6 (en)
ZA (1) ZA927957B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103166B1 (en) * 1992-08-26 1998-04-01 Ciba Geigy Ag PROCEDURE FOR OBTAINING BICYCLE AMIDINOHYDRAZONES.
DE69633557T2 (en) * 1995-01-26 2005-10-13 Novartis Ag IMDAZOL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS S-ADENOSYLMETHIONES DECARBOXYLASE (= SAMDC) INHIBITORS
CA2477714C (en) * 2002-03-04 2011-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg New cinnamic acid salts, processes for the preparation thereof and use thereof as medicament
GT200600316A (en) * 2005-07-20 2007-04-02 SALTS OF 4-METHYL-N- (3- (4-METHYL-IMIDAZOL-1-ILO) -5-TRIFLUOROMETILO-PHENYL) -3- (4-PIRIDINA-3-ILO-PIRIMIDINA-2-ILOAMINO) - BENZAMIDA.
EP1884515A1 (en) 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones

Also Published As

Publication number Publication date
JP2788579B2 (en) 1998-08-20
HUT63149A (en) 1993-07-28
MX9205934A (en) 1993-04-01
FI112212B (en) 2003-11-14
NO924001L (en) 1993-04-19
CZ315292A3 (en) 1993-05-12
RU2081108C1 (en) 1997-06-10
NO178108C (en) 1996-01-24
EP0538193B1 (en) 1996-12-04
SK279938B6 (en) 1999-06-11
ZA927957B (en) 1993-04-26
DK0538193T3 (en) 1996-12-23
GR3021903T3 (en) 1997-03-31
DE59207617D1 (en) 1997-01-16
NO178108B (en) 1995-10-16
IL103448A0 (en) 1993-03-15
CA2080545C (en) 2005-11-29
IL103448A (en) 1998-01-04
AU658931B2 (en) 1995-05-04
CZ279601B6 (en) 1995-05-17
NO924001D0 (en) 1992-10-15
FI924650A0 (en) 1992-10-14
HU9203234D0 (en) 1992-12-28
CA2080545A1 (en) 1993-04-17
KR930007896A (en) 1993-05-20
SA93130417B1 (en) 2005-11-12
HK1005023A1 (en) 1998-12-18
KR100265307B1 (en) 2000-09-15
EP0538193A3 (en) 1993-06-16
HU226954B1 (en) 2010-03-29
NZ244725A (en) 1995-05-26
JPH05239011A (en) 1993-09-17
FI924650A (en) 1993-04-17
ES2095444T3 (en) 1997-02-16
ATE145896T1 (en) 1996-12-15
SK315292A3 (en) 1995-04-12
CY2127B1 (en) 2002-06-21
EP0538193A2 (en) 1993-04-21
SG43185A1 (en) 1997-10-17

Similar Documents

Publication Publication Date Title
FI863013A (en) BAKTERISIDA FRAMSTAELLNINGAR FOER ANVAENDNING INOM VETERINAERMEDICINEN.
IE890177L (en) Piperidinyl derivatives
AU2704092A (en) Salts of hydrazones
AU629298B2 (en) N-substituted aminoalkanediphosphonic acids
ES8106706A1 (en) Benz-acyl-benzimidazole derivatives and antiallergic compositions
GB2160865B (en) Antibacterial penem derivatives
EP0663384A3 (en) Pyromellilic acid salts, process for preparing them and use.
NO950061L (en) 4-oxa-1-azabicyclo [3.2.0Å heptan-7-one derivatives as antitumor agents